BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1034 related articles for article (PubMed ID: 32009783)

  • 1. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.
    Burnouf T; Agrahari V; Agrahari V
    Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
    Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
    Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles: translational challenges and opportunities.
    Clemmens H; Lambert DW
    Biochem Soc Trans; 2018 Oct; 46(5):1073-1082. PubMed ID: 30242120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine.
    Fais S; O'Driscoll L; Borras FE; Buzas E; Camussi G; Cappello F; Carvalho J; Cordeiro da Silva A; Del Portillo H; El Andaloussi S; Ficko Trček T; Furlan R; Hendrix A; Gursel I; Kralj-Iglic V; Kaeffer B; Kosanovic M; Lekka ME; Lipps G; Logozzi M; Marcilla A; Sammar M; Llorente A; Nazarenko I; Oliveira C; Pocsfalvi G; Rajendran L; Raposo G; Rohde E; Siljander P; van Niel G; Vasconcelos MH; Yáñez-Mó M; Yliperttula ML; Zarovni N; Zavec AB; Giebel B
    ACS Nano; 2016 Apr; 10(4):3886-99. PubMed ID: 26978483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered extracellular vesicles and their mimetics for clinical translation.
    Kim H; Kim D; Nam H; Moon S; Kwon YJ; Lee JB
    Methods; 2020 May; 177():80-94. PubMed ID: 31626895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles in the Development of Cancer Therapeutics.
    Sun H; Burrola S; Wu J; Ding WQ
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles (EVs): Comprehensive packages with promises and complications for clinical translation and commercialization.
    Kwon YJ
    Methods; 2020 May; 177():1. PubMed ID: 32145390
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems.
    Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Pluripotent Stem Cell-Derived Extracellular Vesicles: Characteristics and Applications.
    Jeske R; Bejoy J; Marzano M; Li Y
    Tissue Eng Part B Rev; 2020 Apr; 26(2):129-144. PubMed ID: 31847715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis.
    Zarà M; Guidetti GF; Camera M; Canobbio I; Amadio P; Torti M; Tremoli E; Barbieri SS
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation, purification and engineering of extracellular vesicles and their biomedical applications.
    Gao J; Dong X; Wang Z
    Methods; 2020 May; 177():114-125. PubMed ID: 31790730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicles in Cardiovascular Theranostics.
    Bei Y; Das S; Rodosthenous RS; Holvoet P; Vanhaverbeke M; Monteiro MC; Monteiro VVS; Radosinska J; Bartekova M; Jansen F; Li Q; Rajasingh J; Xiao J
    Theranostics; 2017; 7(17):4168-4182. PubMed ID: 29158817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant-derived extracellular vesicles: a novel nanomedicine approach with advantages and challenges.
    Nemati M; Singh B; Mir RA; Nemati M; Babaei A; Ahmadi M; Rasmi Y; Golezani AG; Rezaie J
    Cell Commun Signal; 2022 May; 20(1):69. PubMed ID: 35606749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular communication by extracellular vesicles and their microRNAs in asthma.
    Fujita Y; Yoshioka Y; Ito S; Araya J; Kuwano K; Ochiya T
    Clin Ther; 2014 Jun; 36(6):873-81. PubMed ID: 24909737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicle-based drug delivery systems for cancer treatment.
    Walker S; Busatto S; Pham A; Tian M; Suh A; Carson K; Quintero A; Lafrence M; Malik H; Santana MX; Wolfram J
    Theranostics; 2019; 9(26):8001-8017. PubMed ID: 31754377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles as Natural Nanosized Delivery Systems for Small-Molecule Drugs and Genetic Material: Steps towards the Future Nanomedicines.
    Kotmakçı M; Bozok Çetintaş V
    J Pharm Pharm Sci; 2015; 18(3):396-413. PubMed ID: 26517135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of extracellular vesicles in neurodegenerative diseases.
    Vinaiphat A; Sze SK
    Expert Rev Mol Diagn; 2019 Sep; 19(9):813-824. PubMed ID: 31429341
    [No Abstract]   [Full Text] [Related]  

  • 20. Perspectives in Manipulating EVs for Therapeutic Applications: Focus on Cancer Treatment.
    Nazimek K; Bryniarski K
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.